| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |